![Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=300,fit=contain,format=webp/uploads/assets/research/images/619280d9efec7.jpg)
Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117
Clinicaltrials.gov identifier:
NCT04770246
People with advanced cancer and an inherited PTEN mutation
Study Contact Information:
For additional information, please contact:
Osamu Takahashi, MD, PhD by phone: 609-250-7336 or by email at: [email protected]
Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117
About the Study
This study will look at how well the TAS-117 works for treating people with an inherited mutation and advanced or solid tumors (excluding primary brain tumors). NOTE: this study is no longer enrolling people.
NOTE: this study is no longer enrolling people.
NOTE: this study is no longer enrolling people.